Also, 48 hr after stroke, BML‐111 induced a trend toward an increase in the levels of anti‐inflammatory cytokines IL‐10 and IL‐4 with BML‐111 treatment compared to the vehicle (both p = .1; Figure 4e,f). The gene discussed is IL10; the disease is Stroke.